"Info-AF" Information Preferences in Patients With Atrial Fibrillation/Flutter and the Association With Clinical Symptoms

Atrial Fibrillation Clinical Trial

Official title:

"Info-AF" Information Preferences in Patients With Atrial Fibrillation/Flutter and the Association With Clinical Symptoms

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04299269
• Other study ID #: 1617/2019
• Status: Recruiting
• Phase: N/A
• Start date: February 28, 2020
• Est. completion date: February 2023

Study information

• Verified date: April 2022
• Source: Medical University of Vienna
• Contact: Nikola Schütz, Dr.med.univ.
• Phone: 004314040019640
• Email: nikola.schuetz[@]meduniwien.ac.at
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this project is to identify a variable that discerns patients who are interested in their disease (atrial fibrillation/atrial flutter) from patients who show no interest and furthermore test this theory in a questionnaire survey.

This should help distinguish between patients who are interested in shared decision making and patients who are not (further projects planned).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 130
• Est. completion date: February 2023
• Est. primary completion date: November 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Current atrial fibrillation/flutter

• >18 years of age

• sufficient knowledge of the german language to fill out the questionnaire

Exclusion Criteria:

• < 18 years of age

• insufficient knowledge of the german language to fill out the questionnaire

• Hemodynamic instability

Related Conditions & MeSH terms

• Atrial Fibrillation

Intervention

Other:
• Questionnaire
Questionnaire including questions about Quality of life, symptoms and general informations

Locations

Country	Name	City	State
Austria	AKH Wien	Vienna

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Preferences for autonomy measured with questionnaire	Potential predictors of the outcome are clinical symptoms. Additional covariables will be patient characteristics including age and gender and disease characteristics. Regression analysis will be used as the main statistical method. Descriptive statistics and graphs and inferential statistics will be used as appropriate.	through study completion, an average of 1 year